文献速递烧伤创面修复

舒芬太尼敷料在烧伤创面术后的镇痛疗效

Analgesic efficacy of sufentanil in dressings after surgical treatment of burn wounds.
PubMed 文献 · Burns · 2020-10-16

该研究纳入20例成人Ⅲ度烧伤创面术后患者,比较敷料中添加50μg与25μg舒芬太尼的镇痛效果。结果显示两组血清舒芬太尼均未检出,组1敷料药物浓度较高且补救镇痛需求较少,提示敷料中舒芬太尼浓度应≥0.10 μg/mL。

要点

  • 烧伤术后敷料中添加舒芬太尼可提供有效且安全的镇痛。
  • 敷料中舒芬太尼浓度宜≥0.10 μg/mL(奥替尼啶和苯氧乙醇溶液)。
  • 血清舒芬太尼未检出,未见不良反应。

核心结论

  • 烧伤创面术后敷料中添加舒芬太尼可提供有效且安全的镇痛。
  • 敷料中舒芬太尼浓度应≥0.10 μg/mL(奥替尼啶和苯氧乙醇溶液)。

研究设计与样本

  • 20例成人Ⅲ度烧伤创面术后患者,其中2例接受两次手术。
  • 组1(10例)敷料加50 μg舒芬太尼,组2(10例)加25 μg,术后均用酮洛芬100 mg每日两次。
  • 补救镇痛为皮下注射吗啡5 mg,术后1、2、3、6小时及疼痛时检测血浆舒芬太尼浓度并评估疼痛强度。

主要发现

  • 所有患者血清中均未检测到舒芬太尼。
  • 术后24小时内,组1有1例(接受两次手术者)使用补救吗啡,组2有3例使用补救吗啡。
  • 敷料中舒芬太尼平均浓度组1为0.13 ± 0.03 μg/mL,高于组2的0.06 ± 0.03 μg/mL(p < 0.001)。
  • 组1中使用补救吗啡者敷料舒芬太尼浓度为0.10 μg/mL,为组1最低浓度;组2中使用补救吗啡者浓度为0.03-0.05 μg/mL,至少低两倍。
  • 未观察到不良反应。

关键数值与推荐

  • 敷料中舒芬太尼浓度应≥0.10 μg/mL(奥替尼啶和苯氧乙醇溶液)。
  • 组1敷料舒芬太尼平均浓度0.13 ± 0.03 μg/mL,组2为0.06 ± 0.03 μg/mL(p < 0.001)。
  • 补救镇痛为皮下注射吗啡5 mg。

临床怎么用

  • 烧伤创面术后可在敷料中添加舒芬太尼进行镇痛,浓度建议≥0.10 μg/mL。
  • 需监测补救镇痛需求,若疼痛加剧可使用皮下吗啡5 mg。
  • 血清舒芬太尼未检出,提示全身吸收少,但仍需观察不良反应。

局限性

  • 样本量小(20例,其中2例两次手术)。
  • 仅比较了两种舒芬太尼浓度,未设安慰剂对照。
  • 疼痛强度评估方法与具体数值未在摘要中报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to assess the analgesic efficacy of sufentanil in dressings after surgical treatment of burn wounds. PATIENTS AND METHODS: Twenty adult patients, who underwent surgical treatment of third-degree burn wounds under general anesthesia, were included. Two of the patients underwent surgery twice. During surgery, patients received 50-100 μg fentanyl every 20-30 min and, after surgery, patients received 100 mg ketoprofen twice daily. Additionally, ten patients (group 1) received 50 μg sufentanil added to the burn wound dressings soaked in octenidine and phenoxyethanol while 10 patients (group 2) received 25 μg sufentanil added to the same dressings. The rescue analgesic, which was administered when pain intensified, was 5 mg subcutaneous morphine. Plasma sufentanil concentrations were assayed at 1, 2, 3, and 6 h after surgery completion and when pain was reported, along with pain intensity evaluation. RESULTS: Sufentanil was not detected in the serum of any patients. Rescue morphine was given during the postoperative period (24 h) in one patient in group 1 (who underwent surgery twice) and three patients in group 2. The mean sufentanil concentration in dressings was higher in group 1 (0.13 ± 0.03) than group 2 (0.06 ± 0.03 μg/mL; p < 0.001). The group 1 patient who received rescue morphine had a sufentanil concentration of 0.10 μg/mL, which was the lowest concentration in group 1. Group 2 patients who received rescue morphine had sufentanil concentrations of at least two-fold lower (0.03-0.05 μg/mL). No adverse effects were observed. CONCLUSIONS: Sufentanil in dressings after burn wound surgery provides effective and safe analgesia and the sufentanil concentration in dressings should be ≥0.10 μg/mL in a solution of octenidine and phenoxyethanol.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Kowalski G, Zawadzki M, Leppert W, et al. Analgesic efficacy of sufentanil in dressings after surgical treatment of burn wounds. Burns. 2020. PMID: 33293157. doi:10.1016/j.burns.2020.10.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。